A review of clinical efficacy and safety of canagliflozin 300 mg in the management of patients with type 2 diabetes mellitus

Currently available antihyperglycemic agents, despite being effective, provide inadequate glycemic control and/or are associated with side effects or nonadherence. Canagliflozin, a widely used orally active inhibitor of sodium-glucose cotransporter 2 (SGLT2), is a new addition to the therapeutic arm...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Indian J Endocrinol Metab
Main Authors: Prasanna Kumar, K. M., Ghosh, Sujoy, Canovatchel, William, Garodia, Nishant, Rajashekar, Sujith
Format: Artigo
Sprog:Inglês
Udgivet: Medknow Publications & Media Pvt Ltd 2017
Fag:
Review Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5240065/
https://ncbi.nlm.nih.gov/pubmed/28217522
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2230-8210.196016
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker